LabMedica

Download Mobile App
Recent News Expo
ADLM 2025
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Candida Rapidly Detected by Magnetic Biosensor Test

By LabMedica International staff writers
Posted on 30 May 2011
A magnetic biosensor test detects the fungal pathogen Candida directly in whole blood from patients with the fungal infection.

The new technology enables detection of multiple pathogens and species in a single-process test with rapid diagnostic results within minutes to less than two hours.

Developed by T2 Biosystems (Lexington, MA, USA), magnetic biosensor technology combines nanotechnology with the power of magnetic resonance detection. A "dirty sample" of a patient's blood, saliva, urine, or other biofluid is loaded directly into a desktop instrument via a disposable cartridge. The sample is then mixed with magnetic nanoparticles and analyzed for the presence of specific fungal, bacterial, or viral pathogens, or biomarkers using a technique similar to magnetic resonance imaging (MRI). The system is able to detect low concentrations of target agents or specific pathogens.

In comparison, today's conventional diagnostic technologies use optical signals, require preprocessed biologic samples, and can take days to yield useful results.

Candidemia, a systemic fungal infection that occurs when Candida organisms are present in the blood, is a potentially life-threatening bloodstream infection. Each year, an estimated 60,000 patients contract Candidemia in the United States alone and this incidence continues to rise. It is the most deadly of the common hospital-acquired bloodstream infections, and currently results in significant increased hospital stays, healthcare costs, and patient mortality.

T2 Biosystems, Inc., a company developing next generation diagnostic products, presented data on the rapid and sensitive detection of five Candida species (C. albicans, C. krusei, C. glabrata, C. tropicalis, and C. parapsilosis) at the Annual Meeting of the Mycoses Study Group in Philadelphia (PA, USA) on April 7, 2011.

Related Links:

T2 Biosystems



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
New
Rapid Test Reader
DIA5000

Latest Microbiology News

New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance
30 May 2011  |   Microbiology

Early Detection of Gut Microbiota Metabolite Linked to Atherosclerosis Could Revolutionize Diagnosis
30 May 2011  |   Microbiology

Viral Load Tests Can Help Predict Mpox Severity
30 May 2011  |   Microbiology



PURITAN MEDICAL